Daicel Corporation operates in the materials, medical/healthcare, smart, safety, and engineering plastics businesses in Japan and internationally. Its products include medical/healthcare items such as BELLOCEA S7, FLAVOCELL S-Equol, Urolithin A, polyglycerols, konjac ceramide, excipients, chiral columns and reagents, and Actranza lab, along with separation and analytical services. The company also provides performance films, solvents for electronic materials, cycloaliphatic epoxies, polymers for photoresists, optical lenses, caprolactone derivatives, functional films and materials for smartphones, PCs, TVs, and in-vehicle displays, and lenses for VR, smartphones, and sensors. Additionally, it offers airbag inflators, pyro-fuses, gas generators for seat belt pretensioners, acetic acid and its derivatives, acetate tow, ketene/diketene derivatives, cellulose acetate for LCD optical films, amines, 1,3-butylene glycol, reverse osmosis and ultrafiltration membrane products, and water treatment systems. Its engineering plastics include polyacetal, polybutylene terephthalate, polyphenylene sulfide, liquid crystal polymer, and cyclic olefin copolymer, as well as AS resin, acetate plastics, water-soluble polymers, barrier films for packaging, ABS resins, polymer alloys, plastic compounds, polyamide-12, PEEK resin, and molded containers. These products serve transportation, electronics, medical care, personal care, everyday life, and environment and energy applications. Formerly known as Daicel Chemical Industries, Ltd., it changed its name to Daicel Corporation in October 2011. The company was incorporated in 1919 and is headquartered in Osaka, Japan.